Citation Impact
1 by Nobel laureates 5 from Science/Nature 70 standout
Citing Papers
Renal cell carcinoma
2024 Standout
Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy
2024 Standout
Works of K. Rohrmann being referenced
A clinical phase I/II trial with the monoclonal antibody cG250 (RENCAREX®) and interferon-alpha-2a in metastatic renal cell carcinoma patients
2010
Author Peers
| Author | PRM | Molecular Biology | Surgery | Immunology | Oncology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| K. Rohrmann | 102 | 155 | 33 | 187 | 170 | 9 | 398 | |
| Sara Masoumi | 10 | 5 | 1 | 14 | 502 | |||
| Soghra Fatima | 27 | 389 | 44 | 74 | 116 | 19 | 775 | |
| Leandro Martins de Freitas | 16 | 74 | 1 | 41 | 25 | 18 | 278 | |
| M. Yu | 20 | 68 | 39 | 23 | 8 | 10 | 356 | |
| Jessica L. Staib | 43 | 191 | 9 | 9 | 5 | 8 | 599 |
All Works
Loading papers...